In 2015, the Asian Cancer Research Group (ACRG) reported a similar classification based on mRNA expression profiles, including four subgroups associated with patients’ prognosis: microsatellite-stable (MSS)/TP53-, MSS/TP53+, MSI, and MSS/epithelial-to-mesenchymal transition (4). The gene discussed is TP53; the disease is cancer.